Analyst Ratings for Intercept Pharmaceuticals (ICPT)

ICPT Rating Summary

ICPT Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ICPT
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $193.27 (+66.9%) * Over Last 12-Mos
Rating Score: 6.8 / 10   Percentile Rank: 77%
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
8/5/2016 Laidlaw Downgrade Sell
(Buy)
105.00
(N/A)
163.21 115.80 -29.05% Details
7/6/2016 Cantor Fitzgerald New Coverage Underweight
(N/A)
58.00
(N/A)
143.47 115.80 -19.29% Details
Like ICPT Ratings? Also take a look at GILD, BMRN, INCY, PFE

ICPT Ratings News